Oppenheimer Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,924
| Closed | -$288K | – | 1171 |
|
|
2022
Q4 | $288K | Sell |
3,924
-416
| -10% | -$30.5K | ﹤0.01% | 973 |
|
|
2022
Q3 | $330K | Sell |
4,340
-91
| -2% | -$6.92K | 0.01% | 933 |
|
|
2022
Q2 | $308K | Sell |
4,431
-181
| -4% | -$12.6K | 0.01% | 984 |
|
|
2022
Q1 | $382K | Sell |
4,612
-39
| -0.8% | -$3.23K | 0.01% | 973 |
|
|
2021
Q4 | $349K | Sell |
4,651
-212
| -4% | -$15.9K | ﹤0.01% | 1044 |
|
|
2021
Q3 | $565K | Sell |
4,863
-239
| -5% | -$27.8K | 0.01% | 903 |
|
|
2021
Q2 | $1.13M | Sell |
5,102
-137
| -3% | -$30.4K | 0.02% | 707 |
|
|
2021
Q1 | $692K | Sell |
5,239
-124
| -2% | -$16.4K | 0.01% | 833 |
|
|
2020
Q4 | $928K | Sell |
5,363
-361
| -6% | -$62.5K | 0.02% | 703 |
|
|
2020
Q3 | $637K | Sell |
5,724
-130
| -2% | -$14.5K | 0.01% | 749 |
|
|
2020
Q2 | $347K | Buy |
5,854
+63
| +1% | +$3.73K | 0.01% | 897 |
|
|
2020
Q1 | $390K | Buy |
5,791
+1,701
| +42% | +$115K | 0.01% | 805 |
|
|
2019
Q4 | $345K | Buy |
4,090
+1,596
| +64% | +$135K | 0.01% | 926 |
|
|
2019
Q3 | $187K | Sell |
2,494
-61
| -2% | -$4.57K | ﹤0.01% | 1051 |
|
|
2019
Q2 | $162K | Sell |
2,555
-434
| -15% | -$27.5K | ﹤0.01% | 1097 |
|
|
2019
Q1 | $144K | Sell |
2,989
-1,242
| -29% | -$59.8K | ﹤0.01% | 1122 |
|
|
2018
Q4 | $142K | Buy |
+4,231
| New | +$142K | ﹤0.01% | 1101 |
|